Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco EUR IG Corporate Bond Active UCITS ETF Acc

EUTA · IE000M284BG0 · class Acc · EUR · domicile Ireland
Bonds · Corporate EUR · Broad (all maturities) · GlobalactiveSFDR art. 8
Comparison benchmark: Bloomberg Euro Corporate Index
TER
0.20%+ trans. 0.08%
Fund size
61 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Activeactive management
Income
Accumulating
Duration
4.59 yrsmedium (3–7 years)
Launch 27 May 2026 · costs from the KID as of 14 Aug 2026 · 221 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The investment objective of the Fund is to achieve a combination of income and capital growth over the long-term by investing in an actively-managed portfolio of securities. Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the…

Performance since series start (in euro) — base 100

27 May 20263 Sept 2026 · dividends reinvested where declared by the issuer
1019999
High 101 (26 Jun 2026) · low 99 (2 Sept 2026) · last 99. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start−0.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EUTA · IE000M284BG01
RebalixEUTA · IE000M284BG0 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.5%
Rating breakdown (% of fund)
AAA0.6%AA5.5%A36.5%BBB57.1%Cash and derivatives0.5%
Maturity breakdown (% of fund)
1 to 3 years4.9%3 to 5 years21.3%5 to 10 years47.5%10 to 20 years8.6%20+ years17.4%Cash and derivatives0.5%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 221 securities · top-10 weight = 9.1%
Countries (% of fund)
United States21.3%Other16.8%United Kingdom15.3%France13.7%Germany10.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
EUTA · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE000M284BG0
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EUTA · IE000M284BG02